Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Rena

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Biochemistry|January 18, 2014
Biomolecular mode of action of metformin in relation to its copper binding propertiesPeter Repiščák, Stefan Erhardt, Graham Rena, et al.
JMIR Formative Research|June 10, 2024
Defining Activity Thresholds Triggering a "Stand Hour" for Apple Watch Users: Cross-Sectional StudyKaty Lyons, Alison Hau Hei Man, David Booth, et al.
Metallomics : Integrated Biometal Science|November 12, 2010
Zinc-dependent effects of small molecules on the insulin-sensitive transcription factor FOXO1a and gluconeogenic genesAmy R Cameron, Siji Anil, Emma Sutherland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2020
In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA<sub>1c</sub> lowering is associated with haematological changesSamira M S N'Dow, Louise A Donnelly, Ewan R Pearson, et al.
ACS Sensors|August 5, 2017
New Evidence for the Mechanism of Action of a Type-2 Diabetes Drug Using a Magnetic Bead-Based Automated Biosensing PlatformRokon Uddin, Nur-E-Habiba, Graham Rena, et al.
Diabetes, Obesity & Metabolism|July 3, 2018
Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1)Lisa Logie, Zoe Lees, J William Allwood, et al.
Expert Opinion on Investigational Drugs|March 27, 2023
Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular diseaseAdel Dihoum, Graham Rena, Ewan R Pearson, et al.
Frontiers in Cardiovascular Medicine|October 18, 2021
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for InterventionMohapradeep Mohan, Adel Dihoum, Ify R Mordi, et al.
The Biochemical Journal|January 18, 2012
The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1aAmy R Cameron, Katherine Wallace, Lisa Logie, et al.
Journal of Molecular and Cellular Cardiology Plus|February 24, 2025
In-depth proteomic profiling identifies potentiation of the LPS response by 7-ketocholesterolIain R Phair, Magdalena Sovakova, Noor Alqurashi, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biochemistry|January 18, 2014
Biomolecular mode of action of metformin in relation to its copper binding propertiesPeter Repiščák, Stefan Erhardt, Graham Rena, et al.
JMIR Formative Research|June 10, 2024
Defining Activity Thresholds Triggering a "Stand Hour" for Apple Watch Users: Cross-Sectional StudyKaty Lyons, Alison Hau Hei Man, David Booth, et al.
Metallomics : Integrated Biometal Science|November 12, 2010
Zinc-dependent effects of small molecules on the insulin-sensitive transcription factor FOXO1a and gluconeogenic genesAmy R Cameron, Siji Anil, Emma Sutherland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 25, 2020
In a cohort of individuals with type 2 diabetes using the drug sulfasalazine, HbA<sub>1c</sub> lowering is associated with haematological changesSamira M S N'Dow, Louise A Donnelly, Ewan R Pearson, et al.
ACS Sensors|August 5, 2017
New Evidence for the Mechanism of Action of a Type-2 Diabetes Drug Using a Magnetic Bead-Based Automated Biosensing PlatformRokon Uddin, Nur-E-Habiba, Graham Rena, et al.
Diabetes, Obesity & Metabolism|July 3, 2018
Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1)Lisa Logie, Zoe Lees, J William Allwood, et al.
Expert Opinion on Investigational Drugs|March 27, 2023
Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular diseaseAdel Dihoum, Graham Rena, Ewan R Pearson, et al.
Frontiers in Cardiovascular Medicine|October 18, 2021
Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for InterventionMohapradeep Mohan, Adel Dihoum, Ify R Mordi, et al.
The Biochemical Journal|January 18, 2012
The anti-neurodegenerative agent clioquinol regulates the transcription factor FOXO1aAmy R Cameron, Katherine Wallace, Lisa Logie, et al.
Journal of Molecular and Cellular Cardiology Plus|February 24, 2025
In-depth proteomic profiling identifies potentiation of the LPS response by 7-ketocholesterolIain R Phair, Magdalena Sovakova, Noor Alqurashi, et al.
Pageof 4